Table 1.
Baseline characteristics
| Patients (n = 11) | |
|---|---|
| Age (years) | 58 (53; 68) |
| Male | 10 (91%) |
| Hypertension | 2 (18%) |
| Hypercholesterolemia | 2 (18%) |
| Total cholesterol, mmol/L | 4.9 (4.1; 5.3) |
| Diabetes | 0 |
| Smoking | |
| Non | 5 (46%) |
| Active | 2 (18%) |
| Ex | 4 (36%) |
| Family history of premature CAD | 4 (36%) |
| Peripheral Arterial Disease | 0 |
| Infarct location | |
| LAD | 6 (55%) |
| RCA | 5 (45%) |
| LCX | 0 |
| TIMI flow prior to pPCI | |
| 0 | 5 (46%) |
| 1 | 3 (27%) |
| 2 | 2 (18%) |
| 3 | 1 (9%) |
| TIMI flow post-pPCI | |
| 0 | 0 |
| 1 | 0 |
| 2 | 3 (27%) |
| 3 | 8 (73%) |
| Peak Troponin T (ng/mL) | 3710 (1450; 5850) |
| Peak CK-MB (U/I) | 200 (70.9; 320) |
| Left Ventricle Ejection Fraction post-pPCI (echocardiography) (%) | 40 (35; 50) |
| Time from symptom-onset to PCI (min) | 175 (125; 300) |
| Time door-to-PCI (min) | 27 (24; 29) |
Values are median (interquartile range) or n (%)
CAD, coronary artery disease; LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex artery; TIMI, thrombolysis in myocardial infarction; CK-MB, creatine kinase myocardial band; pPCI, primary percutaneous intervention